Jessica Brown Receives National 2026 Senior Housing & Senior Living Future Leaders Award MYSTIC, Conn., May 20, 2026 /PRNewswire-PRWeb/ -- Academy Point at Mystic, a Benchmark Assisted Living and Mind & Memory Care community, today announced that its Executive Director, Jessica Brown of...
Peytant Solutions, the medical technology company that developed the first and only stent covered with human-derived amniotic membrane to receive FDA De Novo granted clearance, today announced the appointment of Tom Douthitt as chief executive officer. MINNEAPOLIS, May 20, 2026...
Sayulita Wellness Retreat has highlighted its specialized, medically supervised Ibogaine treatment program designed to provide a secure neurological reset for individuals facing addiction, trauma, and burnout. The luxury facility sets a strict industry benchmark for safety by...
Recognition Reflects Employee Experience and Industry Impact SOUTH BEND, Ind., May 20, 2026 /PRNewswire-PRWeb/ -- Harmony Healthcare IT, a leading provider of healthcare data lifecycle management solutions, has been recognized as one of Modern Healthcare's 2026 Best Places to Work in...
Pineapple Family launches as a platform for independent surrogacy and egg donation journeys, replacing the traditional $30,000 to $60,000+ agency model with direct relationships, transparent tools and flat fees starting at $7,500. Founded by two husbands and their gestational carrier....
Amplify Surgical announced the successful completion of what is believed to be the world's first continuously navigated endoscopic transforaminal lumbar interbody fusion (TLIF) procedure, performed at Emory Healthcare by Dr. Daniel Refai and his surgical team. The procedure represents a...
ComplAiance360 is an AI-powered compliance platform built specifically for FQHCs. It monitors HRSA obligations continuously — 340B, FTCA deeming, QI oversight, document management, and incident resolution — so the compliance work runs quietly in the background, and the care work stays...
Today, the World Health Assembly recognized individuals and institutions whose contributions to global health have gone far beyond the call of duty. Six laureates representing diverse backgrounds and contexts were honoured by the President of the Seventy-ninth World Health Assembly, Dr Víctor Elias Atallah Lajam of Dominican Republic, together with representatives of the foundations that have provided these prizes over the last 40 years, and WHO Director-General Dr Tedros Adhanom Ghebreyesus.
The 2026 prizes celebrate the remarkable dedication of the six awardees to advancing primary health care, reducing inequities and bringing the goal of health for all closer to reality. Selected by WHO’s Executive Board in February 2026, the 2026 laureates reflect a shared commitment to improving health outcomes through scientific excellence, innovation and community outreach. Their work ranges from strengthening primary health care systems and advancing disease control to empowering communities and expanding access to essential services for the most vulnerable populations.
This year marks 20 years since the passing of Dr LEE Jong-wook, WHO’s sixth Director-General, who passed away unexpectedly during the World Health Assembly in 2006. One of the prizes awarded today, the Dr LEE Jong-wook Memorial Prize for Public Health, honours his legacy and enduring contribution to global health.
Every year, during the World Health Assembly, public health prizes and awards are presented to individuals and institutions from around the world for their outstanding contributions to public health.
Public health foundation prizes are awarded following nominations submitted by WHO Member States and former laureates. Selection panels composed of representatives of the prize foundations and WHO Executive Board Members review candidates and make recommendations. The WHO Executive Board designates the winners each year, and the awards are presented during a plenary session of the World Health Assembly.
Over the past 15 years, more than 80 laureates from over 50 WHO Member States have received public health prizes. In 2026, nearly 100 nominations were submitted from across all six WHO regions, reflecting a significant increase in global engagement in recognizing public health excellence.
Dedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life.
We are the UN agency for health that connects nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable.
“Together for health. Stand with science”, the theme of World Health Day 2026 marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide.
CoolVida by Res-Q is responding to the growing demand for non-hormonal menopause support with a clinically researched formula designed to help manage hot flashes, night sweats, sleep disruption, and temperature fluctuations naturally. Featuring patented geniVida® TG genistein, CoolVida...
At a time when prices continue to rise across nearly every category, Bosley is lowering its standard hair transplant pricing to make physician-led hair restoration more accessible. BEVERLY HILLS, Calif., May 19, 2026 /PRNewswire-PRWeb/ -- Bosley, America's #1 Hair Restoration Expert® and...
Practice Transitions Group served as the exclusive sell-side advisor on the Preva Aesthetics transaction, with Lauren Wheeler as lead advisor. AUSTIN, Texas, May 19, 2026 /PRNewswire-PRWeb/ -- Practice Transitions Group (PTG), a sell-side M&A advisory firm representing healthcare practice...
New center will provide compassionate, evidence-based support for individuals and families across the greater Wichita region ANDOVER, Kan., May 19, 2026 /PRNewswire-PRWeb/ -- LifeSpring Recovery of Andover, in partnership with Ascension Recovery Services, today announced the grand opening...
New offerings extend the daily learning platform — already used by over 10,000 SRNAs and CRNAs — to registered nurses. DETROIT, May 19, 2026 /PRNewswire-PRWeb/ -- Ollivate, the daily learning platform for nurse anesthesia professionals, today announced the launch of two new offerings for...
WhisperQuake has completed a proof of concept showing that core parts of its method can move into AI-supported software behavior while supporting a person's own meaning, not just their words. FORT WORTH, Texas, May 19, 2026 /PRNewswire-PRWeb/ -- Proof of concept shows core parts of the...
New platform founded by Jennifer Gelles and Rania Chami expands access to trusted education, community engagement, and future wellness innovation for women ages 35 to 55 navigating perimenopause, menopause, and hormone health transitions. LOS ANGELES, May 19, 2026 /PRNewswire-PRWeb/ --...
Accessible, unbiased education and support resources are now available in English and Spanish to help families better navigate breastfeeding, pumping, and early parenting beyond traditional equipment fulfillment. NORTH ANDOVER, Mass., May 19, 2026 /PRNewswire-PRWeb/ -- Acelleron, a...
Industry Leader Shares Insights on a Landmark Herpetological Discovery and Its Implications for the Reptile-Keeping Community EVANSVILLE, Ind., May 19, 2026 /PRNewswire-PRWeb/ -- RodentPro.com®, the industry leader in premium-quality animal nutrition and supplies since 1993, is sharing...
The 99 Lives Cat Genome Sequencing Initiative has achieved major scientific milestones by creating 1,000+ cat datasets WYCKOFF, N.J., May 19, 2026 /PRNewswire-PRWeb/ -- EveryCat Health Foundation, the world's leading granting foundation solely focused on advancing feline health through...
The Seventy-ninth session of the World Health Assembly (WHA79) opened in Geneva, Switzerland today, with the election of Dr Víctor Elías Atallah Lajam of the Dominican Republic as the President of the Health Assembly.
The elected Vice-Presidents are Dr Mohamed Ali Al-Ghouj of Libya, Dr Assa Badiallo Touré of Mali, Mrs Katarzyna Drążek -Laskowska of Poland, Mrs Neesha Mehta of Nepal, and Mr Elias Kapavore of Papua New Guinea. Dr Timur Sultangaziyev of Kazakhstan and Dr Kwabena Mintah Akandoh of Ghana are the Chairs of the Committee A and Committee B, respectively.
During the high-level welcome, H.E. Elisabeth Baume‑Schneider, Federal Councillor of the Swiss Confederation, addressed the Health Assembly on behalf of the host country, followed by remarks from H.E. John Dramani Mahama, President of Ghana and Special Guest of Honour.
Delegates also heard video messages from H.E. António Guterres, United Nations Secretary‑General, H.E. Ahmad Al Sharaa, President of the Syrian Arab Republic, and H.E. Mia Mottley, Prime Minister of Barbados.
Dr Tedros Adhanom Ghebreyesus, WHO Director‑General, addressed the Assembly and then presented the Awards for Global Health to Dr Tore Godal, Dr Merceline Dahl-Regis, Dr Mike Ryan and Dr Heba El Sewedy, recognizing their lifetime achievements and exceptional contributions to improving the health and well-being of communities worldwide.
Special Guest, H.E. Pedro Sanchez, Prime Minister of Spain, addressed the Assembly at the conclusion of the afternoon session in the Plenary.
New Jacksonville-based research facility will study exertional heat illness, occupational heat safety, and wearable device validation in expansion with UConn's Korey Stringer Institute. JACKSONVILLE, Fla., May 18, 2026 /PRNewswire-PRWeb/ -- Perry Weather, a leading weather safety...
A two-time cancer survivor is trekking 540km across Türkiye to fund rural cancer screenings and support Movember. CHARLESTON, S.C., May 18, 2026 /PRNewswire-PRWeb/ -- Jason Cronen's cancer journey began in 2004 with a devastating Stage Three cancer diagnosis while a student at the College...
Kreate Medical has received two FDA 510(k) clearances for its innovative wound matrix products, including Antibacterial Absorbable Synthetic Matrix and Absorbable Synthetic Matrix. These dual clearances mark their entry into the US market and the debut of a versatile portfolio designed to...
At the Seventy-ninth World Health Assembly in Geneva, WHO Director-General Dr Tedros Adhanom Ghebreyesus has presented four distinguished leaders with the Award for Global Health, recognizing their lifetime achievements and exceptional contributions to improving the health and well-being of communities worldwide.
This year’s laureates are Dr Tore Godal, Dr Merceline Dahl-Regis, Dr Mike Ryan and Dr Heba El Sewedy. They were celebrated during the High-Level Welcome of the World Health Assembly (WHA), held this year under the theme “Reshaping global health: a shared responsibility.”
Established in 2019, the Director-General’s Awards for Global Health recognize individuals whose leadership and commitment have delivered tangible improvements in health outcomes around the world.
“I am honoured to present the Global Health Leaders Awards to four individuals who have made outstanding lifetime contributions to global health,” said Dr Tedros.
Dr Tore Godal was recognized for his transformative leadership in immunization and infectious diseases. Throughout his distinguished career, he played a pivotal role in elevating vaccines as a global development priority and helped establish major initiatives including Gavi, the Vaccine Alliance, Roll Back Malaria and CEPI, the Coalition for Epidemic Preparedness Innovations. He also played a pivotal role in the fight against neglected diseases when leading WHO’s Tropical Diseases Programme, and expanding work on leprosy and malaria. He helped expand community-based ivermectin distribution and onchocerciasis control efforts, which contributed to protecting large populations from river blindness. Dr Godal’s work has translated scientific research into large-scale public health action, protecting millions of lives.
Dr Merceline Dahl-Regis was recognized for her lifelong commitment in expanding immunization and disease elimination in the Region of the Americas and beyond. Her contributions were instrumental in achieving the elimination of measles and rubella in the Americas – the first region in the world to reach this milestone. Her advocacy and support of the regional Dual Elimination Initiative also supported the elimination of mother-to-child transmission of syphilis and HIV in the Americas. Through research, community engagement and regional collaboration, she has advanced a holistic approach to health and development and had a profound impact on the lives of many people in the Americas and globally.
Dr Mike Ryan was honoured for his leadership in strengthening global preparedness for and response to health emergencies. A founder of the Global Outbreak Alert and Response Network (GOARN), he has shaped international systems for detecting and responding to epidemics, and – when serving as the Executive Director of WHO’s Health Emergencies Programme – led operational responses to SARS, cholera, Ebola, polio and COVID-19. His leadership during major outbreaks and humanitarian crises working in some of the most challenging environments has demonstrated an unwavering commitment to protecting vulnerable communities and advancing global health security.
Dr Heba Elsewedy received the award for her dedication to humanitarian action and social justice. Through the Ahl Masr Foundation, which she founded in 2013, she has pioneered comprehensive approaches to the prevention and treatment of trauma and burn injuries, while promoting awareness, dignity and the reintegration of survivors. Dr Heba Elsewedy's foundation has been instrumental in providing medical and psychological support to burn victims, as well as humanitarian aid to those affected by the Gaza conflict. Her work has transformed lives and stands as a model of compassionate, people-centred care, and a source of inspiration for many young public health advocates.
From steering large-public health actions, to leading scientific innovations, engaging with communities and protecting people against emergencies and infectious diseases, the 2026 awardees reflect the diversity of approaches needed to achieve the highest possible level of health for all. Their achievements serve as a source of inspiration for current and future generations working for a healthier, safer and more equitable world for all.
To the people of Tenerife,
My name is Tedros, and I serve as the Director-General of the World Health Organization, the United Nations agency responsible for global public health. It is not common for me to write directly to the people of a single community, but today I feel it is not only appropriate, it is necessary.
I want to speak to you directly, not through press releases or technical briefings, but as one human being to another, because you deserve that.
I know you are worried. I know that when you hear the word “outbreak” and watch a ship sail toward your shores, memories surface that none of us have fully put to rest. The pain of 2020 is still real, and I do not dismiss it for a single moment.
But I need you to hear me clearly: this is not another COVID. The current public health risk from hantavirus remains low. My colleagues and I have said this unequivocally, and I will say it again to you now.
The virus aboard the MV Hondius is the Andes strain of hantavirus. It is serious. Three people have lost their lives, and our hearts go out to their families. The risk to you, living your daily life in Tenerife, is low. This is the WHO’s assessment, and we do not make it lightly.
Right now, there are no symptomatic passengers on board. A WHO expert is on that ship. Medical supplies are in place. Spain’s authorities have prepared a careful, step-by-step plan: passengers will be ferried ashore at the industrial port of Granadilla, far from residential areas, in sealed, guarded vehicles, through a completely cordoned-off corridor, and repatriated directly to their home countries. You will not encounter them. Your families will not encounter them.
I also want to say something else, something that goes beyond the science.
I personally thanked Prime Minister Sanchez for Spain’s decision to receive this ship. I called it an act of solidarity and moral duty. Because that is what it is. I want you to know that the WHO’s request to Spain was not made arbitrarily. It was made in full accordance with the International Health Regulations, the legally binding framework that defines the rights and obligations of countries and the WHO when responding to public health events of international concern. Under those rules, the nearest port with sufficient medical capacity must be identified to ensure the safety and dignity of those on board. Tenerife met that standard. Spain honoured it. Nearly 150 people from 23 countries have been at sea for weeks, some of them grieving, all of them frightened, all of them longing for home. Tenerife has been chosen because it has the medical capacity, the infrastructure, and the humanity to help them reach safety.
And because I believe that so deeply, I will be there myself. I intend to travel to Tenerife to observe this operation firsthand, to stand alongside the health workers, port staff, and officials who are making it happen, and to personally pay my respects to an island that has responded to a difficult situation with grace, solidarity, and compassion. Your humanity deserves to be witnessed, not just acknowledged from a distance.
As I have said many times: viruses do not care about politics, and they do not respect borders. The best immunity any of us has is solidarity.
Tenerife is demonstrating that solidarity today. The ship’s captain, Jan Dobrogowski, crew and the company operating the vessel have shown exemplary collaboration at this challenging time. On behalf of the World Health Organization, and on behalf of those passengers and their families around the world, I thank the people of Tenerife and everyone else involved.
Please take care of yourselves and of each other. Trust in the preparations that have been made. And know that the WHO stands with you, and with every person on that ship, every step of the way.
With respect, care, and gratitude,
Tedros
Dr Tedros Adhanom Ghebreyesus
Director-General, World Health Organization
Dr Tedros Adhanom Ghebreyesus, WHO Director-General, briefed media today on a cluster of hantavirus cases linked to a cruise ship, the MV Hondius.
Eight cases have been reported so far, including three deaths. Five of the 8 cases have been confirmed as hantavirus.
The hantavirus involved is the Andes virus, the only species known to be capable of limited transmission between humans, linked to close and prolonged contact.
Describing the situation, Dr Tedros said, “While this is a serious incident, WHO assesses the public health risk as low.” He noted that given the incubation period, “it’s possible that more cases may be reported.”
WHO is coordinating closely with multiple countries under the International Health Regulations or IHR, rules that define the rights and obligations of countries and WHO in responding to public health events. This event demonstrates why the IHR exist, demonstrating the importance of global cooperation and solidarity in responding to health threats that know no borders.
“Our priorities are to ensure the affected patients receive care, that the remaining passengers on the ship are kept safe and treated with dignity, and to prevent any further spread of the virus,” Dr Tedros said.
WHO has taken a number of actions since it was notified of the situation on Saturday, 2 May 2026. The latest of these include deploying an expert on board the ship, to support a comprehensive medical assessment of all passengers and crew, while gathering critical information to evaluate their risk of infection.
WHO has arranged for the shipment of 2500 diagnostic kits from Argentina to laboratories in five countries to strengthen testing capacity. The Organization is also developing step-by-step operational guidance for the safe and respectful disembarkation and onward travel of passengers and crew when they arrive.
Watch the full press conference
Member States of the World Health Organization (WHO) have progressed work on the Pathogen Access and Benefit Sharing (PABS) annex, a key part of the WHO Pandemic Agreement, and today agreed additional time was needed to finalize the framework for ensuring a better, more equitable, response to future pandemics.
Countries today ended the resumed session of the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement in Geneva, focused on the PABS system. The outcome of this work will be presented to the Seventy-ninth World Health Assembly (WHA) later this month. Given the need for further negotiations, the Assembly will be asked to consider continuing IGWG’s work as mandated in Resolution WHA78.1 and submit the outcome to the next Assembly in May 2027, or earlier by a special session of WHA in 2026.
“Real progress was made on the PABS annex and I am confident through continued negotiations differences will be overcome,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “Member States should continue approaching the outstanding issues with a sense of urgency because the next pandemic is a matter of when, not if. The PABS annex is the last piece of the puzzle not only for the Pandemic Agreement but all initiatives that WHO and Member States have implemented as a result of lessons learned from the COVID-19 pandemic.”
The PABS system is intended to ensure, on equal footing, the rapid sharing of pathogens with pandemic potential and the fair and equitable sharing of benefits arising from their use, such as vaccines, diagnostics and therapeutics. Finalizing the PABS Annex is necessary so countries can proceed with signature and ratification of the Pandemic Agreement.
“Finalizing a document of such technical and legal complexity requires precision and dedication, both of which the Member States have demonstrated in full,” said IGWG Bureau Co-Chair Ambassador Tovar da Silva Nunes of Brazil. “We are not there yet, but with an extension of our negotiations, we will get there.”
IGWG Co-Chair Mr Matthew Harpur said: “WHO Member States have demonstrated strong and continuing commitment to negotiations on a Pathogen Access and Benefit Sharing system annex. The IGWG Bureau is confident we are moving in the right direction to finalize the PABS annex, and in doing so provide the WHO Pandemic Agreement with the framework needed to ensure countries are better, and more equitably, prepared and protected for the next pandemic.”
The IGWG will hold its seventh meeting from 6 to 17 July 2026.
In May 2025, the World Health Assembly adopted the WHO Pandemic Agreement to strengthen how countries prevent, prepare for, and respond to pandemics. It also established an open-ended Intergovernmental Working Group (IGWG) to carry out key tasks, including drafting and negotiating the PABS system.
Global efforts to combat viral hepatitis are delivering measurable progress in reducing infections and deaths, but the disease remains a major global health challenge, according to a new World Health Organization (WHO) report released today at the World Hepatitis Summit.
Viral hepatitis B and C – the two infections responsible for 95% of hepatitis-related deaths worldwide – claimed 1.34 million lives in 2024, the latest data show. At the same time, transmission continues, with more than 4900 new infections every day, or 1.8 million each year.
The 2026 Global hepatitis report documents significant gains made since 2015. The annual number of new hepatitis B infections has dropped by 32% and hepatitis C-related deaths have fallen by 12% globally. Hepatitis B prevalence among children under five has also decreased to 0.6%, with 85 countries achieving or surpassing the 2030 target of 0.1%.
These achievements reflect the impact of sustained, coordinated global and national action following the adoption of WHO viral hepatitis elimination targets by Member States at the World Health Assembly in 2016. However, the report warns that current rates of progress are insufficient to meet all 2030 elimination targets, underscoring the urgent need to accelerate prevention, testing, and treatment efforts worldwide.
“Around the world, countries are showing that eliminating hepatitis is not a pipedream, it's possible with sustained political commitment, backed by reliable domestic financing,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “At the same time, this report shows that progress is too slow and uneven. Many people remain undiagnosed and untreated due to stigma, weak health systems and inequitable access to care. While we have the tools to eliminate hepatitis as a public health threat, urgent scale-up of prevention, diagnosis and treatment is needed if the world is to meet the 2030 targets.”
Updated WHO estimates indicate that 287 million people were living with chronic hepatitis B or C infection in 2024.
That year, 0.9 million people were newly infected with hepatitis B. The WHO African Region accounted for 68% of new hepatitis B infections, yet only 17% of newborns in the region received the hepatitis B birth-dose vaccination.
A further 0.9 million hepatitis C infections were recorded in 2024. People who inject drugs accounted for 44% of new infections, highlighting the urgent need for stronger harm reduction services and safe injection practices.
Of the 240 million people with chronic hepatitis B in 2024, fewer than 5% were receiving treatment. Only 20% of people with hepatitis C have been treated since 2015, when a new 12-week treatment with a cure rate of about 95% became available.
As a result of limited access to prevention and care, in 2024 an estimated 1.1 million people died from hepatitis B and 240 000 from hepatitis C. Liver cirrhosis and hepatocellular carcinoma were the main causes of hepatitis related deaths. A large share of hepatitis B-related deaths occurred in the African and Western Pacific Regions.
Ten countries – Bangladesh, China, Ethiopia, Ghana, India, Indonesia, Nigeria, the Philippines, South Africa and Viet Nam – accounted for 69% of hepatitis B related deaths worldwide in 2024. Hepatitis C-related deaths are more geographically dispersed. In 2024, ten countries accounted for 58% of the global total: China, India, Indonesia, Japan, Nigeria, Pakistan, the Russian Federation, South Africa, the United States of America and Viet Nam.
Despite these challenges, progress in countries such as Egypt, Georgia, Rwanda, and the United Kingdom demonstrates that eliminating hepatitis as a public health problem is achievable with sustained commitment and investment.
Highly effective tools are already available:
“The data shows that progress is possible but also reveals where we are falling short. Every missed diagnosis and untreated infection due to chronic viral hepatitis represents a preventable death,” said Dr Tereza Kasaeva, Director, WHO Department for HIV, TB, Hepatitis and Sexually Transmitted Infections. “Countries must move faster to integrate hepatitis services for people living with hepatitis B and C into primary care, and to reach the communities most affected.”
The report identifies priority actions to accelerate hepatis elimination as a public health threat. These include scaling up treatment for chronic hepatitis B infection, particularly in the WHO African and Western Pacific regions, and expanding access to hepatitis C treatment in the WHO Eastern Mediterranean Region.
It also calls for stronger political commitment and financing, improved coverage of hepatitis B birth-dose vaccination and expanded antiviral prophylaxis to prevent mother-to-child transmission of HBV infection, particularly in the WHO African Region. In addition, the report emphasizes the need to improve injection safety in both health-care settings and community practices, including through strengthened harm reduction services for people who inject drugs.
The World Health Organization (WHO) wrapped up Exercise Polaris II, a 2-day high-level simulation exercise, based around an outbreak of a fictional new bacterium spreading across the world. Bringing together 26 countries and territories, 600 health emergency experts and over 25 partners, the exercise, which took place on 22 and 23 April, allowed countries to test their preparedness for pandemics and other major health emergencies, including activating their emergency workforce structures, information flow and coordination with each other, partners and WHO.
Building on the success of Polaris I held in April 2025, which centered on a fictional virus, each participating country activated its emergency coordination structure and worked under real-life conditions to share information, align policies and surge their workforce.
“Exercise Polaris II showed what is possible when we act together. It demonstrated that global cooperation is not optional – it is essential,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “This is the purpose of the Global Health Emergency Corps: coordination across the emergency workforce, building trust, strengthening connections, and working as one across borders.”
The simulation put two key WHO frameworks into practice, the Global Health Emergency Corps (GHEC) framework and the National health emergency alert and response framework, and explored the use of AI-enabled tools to support workforce organization and planning.
The GHEC framework, published in June 2025, provides guidance on how countries can strengthen their health workforce to respond to emergencies based on the principles of sovereignty, equity and solidarity. It improves collaboration between countries by supporting information exchange and strengthening the deployment of regional and global emergency personnel when needed.
The National health emergency alert and response framework, published in October 2025 outlines the key functions, coordination systems and actions needed for an effective response at local, sub-national and national levels.
“By simulating the spread of a dangerous pathogen under real-life conditions, Exercise Polaris II helped us turn existing plans into action. It is not enough to have plans on paper – what matters is how they perform in practice,” said Edenilo Baltazar Barreira Filho, Director of the Public Health Emergencies Department, Ministry of Health, Brazil.
The exercise also provided an opportunity to practice a coordinated provision of technical expertise and surge support to countries from over 25 national, regional and global health agencies and organizations, including Africa Centres for Disease Control and Prevention, the International Federation of Red Cross and Red Crescent Societies, Médecins Sans Frontières, Robert Koch Institute, UK-Med, UNICEF, and emergency networks such as the Global Outbreak Alert and Response Network, the Emergency Medical Teams initiative, Standby Partners, and the International Association of National Public Health Institutes.
“Exercise Polaris II showed what it looks like when countries are prepared and ready to act together,” said Dr Chikwe Ihekweazu, Executive Director of WHO’s Health Emergencies Programme. “This reflects the spirit of the Global Health Emergency Corps: a well-organized, trained, coordinated and connected emergency workforce ready to respond wherever and whenever it is needed.”
The second edition of the exercise saw a larger number of countries participate and collaborate through new networks such as the recently launched Health Emergency Leaders Network for Africa and the Eastern Mediterranean.
Exercise Polaris II is part of HorizonX, WHO’s forward-looking, multi-year simulation exercise programme. It provides a vital platform to operationalize and practice emergency frameworks under real-life conditions, ensuring that collective readiness is not a periodic effort, but a continuous investment in global health security.
Participating countries and territories covering all WHO regions included Bangladesh, Brazil, Brunei, Colombia, Egypt, El Salvador, France, Georgia, Ghana, India, Indonesia, Jordan, Kenya, Kosovo*, Libya, Malaysia, Nepal, Oman, Paraguay, Philippines, Qatar, Republic of Congo, Rwanda, Suriname, Thailand, and Yemen.
*All references to Kosovo on this page should be understood to be in the context of the United Nations Security Council resolution 1244 (1999).
About WHO
Dedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life. We are the United Nations’ agency for health that connects nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable. “Together for health. Stand with science”, the theme of World Health Day 2026 marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide.
Ahead of World Malaria Day on 25 April, the World Health Organization (WHO) has announced a significant step forward in the fight against malaria with the prequalification of the first treatment developed specifically for newborns and young infants weighing between two and five kilograms. The prequalification designation indicates that the medicine meets international standards of quality, safety and efficacy, and will help to expand access to quality-assured treatment for one of the most underserved patient groups.
The newly prequalified treatment, artemether-lumefantrine, is the first antimalarial formulation designed specifically for the youngest malaria patients. Until now, infants with malaria have been treated with formulations intended for older children, which increase the risk of dosing errors, side effects and toxicity. WHO prequalification will enable public sector procurement, contributing to closing a long-standing treatment gap for some 30 million babies born each year in malaria-endemic areas of Africa.
"For centuries, malaria has stolen children from their parents, and health, wealth and hope from communities," said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. "But today, the story is changing. New vaccines, diagnostic tests, next-generation mosquito nets and effective medicines, including those adapted for the youngest, are helping to turn the tide. Ending malaria in our lifetime is no longer a dream – it is a real possibility, but only with sustained political and financial commitment. Now we can. Now we must."
On 14 April 2026, WHO also prequalified three new rapid diagnostic tests (RDTs) designed to address emerging diagnostic challenges for malaria. The most common malaria RDTs for P.falciparum parasite work by detecting the protein, known as HRP2. But based on reported studies and surveys in 46 countries, some strains of the malaria parasite have lost the gene that makes this protein – so they become "invisible" to HRP2-based RDTs, leading to false-negative results. In countries in the Horn of Africa, up to 80% of cases were missed, leading to delayed treatment, severe illness, and even death.
The new tests address this issue by targeting a different parasite protein (pf-LDH) that the malaria parasite cannot easily shed. They provide a reliable, quality-assured alternative where HRP2-based tests are failing. WHO now recommends that countries switch to these alternative RDTs when more than 5% of cases are missed due to pf-hrp2 deletions. This ensures accurate diagnosis, appropriate treatment, and protects hard-won malaria control gains – especially for the most vulnerable communities.
The announcements come as WHO and partners launch the 2026 World Malaria Day campaign, "Driven to End Malaria: Now We Can. Now We Must." The theme is a rallying cry to seize the moment – to protect lives now and fund a malaria-free future.
According to the World malaria report 2025, there were an estimated 282 million cases and 610 000 deaths in 2024 – an increase from 2023. While 47 countries have been certified malaria-free and 37 countries reported fewer than 1000 cases in 2024, progress at the global level is stalling. Gains are at risk due to multiple challenges, including drug resistance, insecticide resistance, diagnostic failure, and severe reductions in international development assistance.
Despite these challenges, substantial progress has been made, with an estimated 2.3 billion malaria infections prevented and 14 million lives saved worldwide since 2000.
Twenty-five countries are now rolling out malaria vaccines, protecting millions of children, and next-generation mosquito nets make up 84% of all new nets distributed. These advances demonstrate what is possible when all partners work together to innovate and deliver on the promises towards ending malaria for all.
Dedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life. We are the UN agency for health that connects nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable.
“Together for health. Stand with science”, the theme of World Health Day 2026 marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide.
The Big Catch-Up (BCU), a historic multi-year, multi-country effort to address vaccination declines driven largely by the COVID-19 pandemic, has reached an estimated 18.3 million children aged 1 to 5 across 36 countries with more than 100 million doses of life-saving vaccines, helping to narrow critical immunity gaps, announced Gavi, the Vaccine Alliance (Gavi), WHO, and UNICEF at the start of World Immunization Week.
Of the 18.3 million children reached between 2023 and 2025, an estimated 12.3 million were “zero-dose children” who had not yet received a vaccine and 15 million had never received a measles vaccine. BCU also provided 23 million doses of inactivated polio vaccine (IPV) to un- and under-vaccinated children, an essential intervention to reach polio eradication. Programme implementation concluded on 31 March 2026. Although final data is still being compiled, the global initiative is forecasted to be on track to meet its target of reaching at least 21 million un- and under-immunized children.
However, agencies warn that while catch-up vaccination is an important strategy for closing immunisation gaps, expanding the reach of routine immunization programmes remains the most effective and sustainable way to protect children and prevent outbreaks of vaccine-preventable diseases.
Beyond pandemic recovery, the BCU initiative focused on closing the vaccine equity gap. Millions of children every year miss the essential vaccinations they should receive before the age of one. Most of them live in fragile, conflict-affected, or underserved communities and are never caught up as they grow older.
The 36 participating BCU countries across Africa and Asia currently account for 60% of all zero-dose worldwide. Pandemic-related immunisation programme disruptions exacerbated this issue, and, in these countries, added millions more zero-dose children to those who already chronically miss out. To address this issue, the Big Catch-Up looked beyond infant immunization, for the first-time ever systematically leveraging routine immunisation systems to make deep inroads into the accumulated global cohort of older children between the ages of 1 to 5 – “older” because they should have received critical routine vaccines before the age of 1 – who remain vulnerable due to missed vaccinations.
BCU catalysed long-lasting systems to identify, screen, vaccinate and monitor coverage rates in these older children – including updates to policies on age eligibility. Countries also oriented and trained health workers to identify, screen and vaccinate missed children as part of routine care and engaged with communities and civil society to support catch-up efforts. By expanding the reach of immunization to millions of previously missed children and their communities, and investing in systemic improvements, the BCU drive has made it easier for the countries to ensure these populations and others like them continue to receive essential health and immunization services in the future.
Among the participating countries, 12 countries (Burkina Faso, Democratic People’s Republic of Korea, Ethiopia, Kenya, Madagascar, Mauritania, Niger, Pakistan, Somalia, Togo, United Republic of Tanzania, and Zambia) reported reaching more than 60% of all zero-dose children under the age of 5 who had previously missed DTP1. In Ethiopia, more than 2.5 million previously zero-dose children received DTP1. The country also delivered nearly 5 million doses of IPV and more than 4 million doses of measles vaccine, among other key vaccines, to un- and under-vaccinated children. Countries outside this group also reached large numbers of children. In Nigeria, for example, 2 million previously zero-dose children were reached with DTP1, and 3.4 million doses of IPV were administered alongside millions of doses of other vaccines.
While these 36 countries received Gavi funding and technical assistance from WHO and UNICEF through BCU, many other countries also implemented activities during this period to accelerate efforts to catch-up missed children and recover immunisation services following pandemic-related backsliding.
“As the largest ever international effort to reach missed children with life-saving vaccines, the Big Catch-Up shows what is possible when governments, partners and communities work together to protect the most vulnerable in society,” said Dr Sania Nishtar, CEO of Gavi, the Vaccine Alliance. “Thanks to this accomplishment, not only are millions of children now protected from preventable diseases but so are their communities, for generations to come.”
"By protecting children who missed out on vaccinations because of disruptions to health services caused by COVID-19, the Big Catch-Up has helped to undo one of the pandemic's major negative consequences," said Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization. “The success of the Big Catch-Up is a testament to health workers and national immunization programmes, which are now better equipped to find and vaccinate children missed by routine services."
"Vaccinations save lives,” said UNICEF Executive Director Catherine Russell. “This initiative shows what's possible when countries have the resources, tools, and political will to reach children with lifesaving vaccines. We've caught up with some of the children who missed routine vaccinations during the pandemic – but many more remain out of reach. The gains made through the Big Catch-Up must be sustained through investment in strong, reliable immunisation systems, especially at a time where measles is resurging."
Through the Big Catch-Up, for the first time ever, countries and global partners successfully reached 12.3 million “older” zero dose children between the ages of 1 to 5. However, in 2024, an estimated 14.3 million infants under the age of one globally failed to receive a single vaccine through routine immunization programmes. Despite BCU demonstrating progress is possible with leadership and targeted investment and support, lowering this annual number of infants who miss out will require building systems that consistently reach the hardest to reach communities – against a backdrop of rising birth cohorts, conflict and displacement, funding cuts, and strained health systems.
The consequences of chronic gaps in routine immunisation are plain to see. Measles outbreaks, for example, are rising in every region with around 11 million cases in 2024, and the number of countries facing large outbreaks has almost tripled since 2021. This surge is driven by persistent gaps in measles vaccination through routine immunization programmes, compounded by declining vaccine confidence in some previously high-coverage communities.
Large-scale catch-up efforts are resource intensive and should serve only as a gap-filling measure that is complementary to routine immunization. Timely vaccination according to national immunization schedules provides optimal protection and continues to be the most sustainable way to safeguard children and communities.
WHO, UNICEF, and Gavi, along with countries and communities, are marking World Immunization Week (24–30 April 2026) with a joint campaign, "For every generation, vaccines work," calling on countries to sustain and expand vaccination coverage at every age. At the midpoint of the Immunisation Agenda 2030 (IA2030), and central to Gavi's 2026–2030 strategy (Gavi 6.0), the priority remains the same: reaching zero-dose children and advancing equity in the hardest-to-reach communities, particularly in countries grappling with conflict, instability, or fragile health systems. Maintaining that momentum will require expanding long-term domestic investments in immunization programmes and reliable commitments from partners and donors.
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world’s deadliest diseases. The Vaccine Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Gates Foundation and other private sector partners. View the full list of donor governments and other leading organisations that fund Gavi’s work here.
Since its inception in 2000, Gavi has helped to immunise a whole generation – over 1.2 billion children – and prevented more than 20.6 million future deaths, helping to halve child mortality in 78 lower-income countries. Gavi also plays a key role in improving global health security by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningococcal and yellow fever vaccines. After two decades of progress, Gavi is now focused on protecting the next generation, above all the zero-dose children who have not received even a single vaccine shot. The Vaccine Alliance employs innovative finance and the latest technology – from drones to biometrics – to save lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency. Learn more at www.gavi.org and connect with us on Bluesky, Facebook, Instagram, LinkedIn, TikTok, X and YouTube.
UNICEF, the United Nations agency for children, works to protect the rights of every child, everywhere, especially the most disadvantaged children and in the toughest places to reach. Across more than 190 countries and territories, we do whatever it takes to help children survive, thrive, and fulfil their potential.
For more information about UNICEF and its work, please visit: www.unicef.org Follow UNICEF on X (Twitter), Facebook, Instagram, and YouTube
Dedicated to the health and well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere, an equal chance at a safe and healthy life. We are the UN agency for health. We connect nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable. www.who.int
The World Health Organization (WHO) today released its Results Report, highlighting measurable improvements in people’s health worldwide in 2025, despite funding cuts affecting both the organization and the broader global health sector.
Published at a pivotal moment for global health, the Results Report demonstrates that WHO’s impact was strongest in areas where its technical leadership and comparative advantage were fully leveraged.
The report finds significant progress across all three “Triple Billion” targets under WHO’s Thirteenth General Programme of Work (GPW13) for 2019–2025.
Despite this progress, the report cautions that important ambitions remain unmet, leaving with the world off track to meet the health-related Sustainable Development Goals by 2030.
Nevertheless, this final snapshot under GPW 13 provides clear evidence of the value of a strong and sustainably financed WHO, reflecting enduring collaboration between WHO and its Member States at global, regional and country levels.
“The Results Report 2025 shows that with support from WHO and partners, countries have delivered tangible benefits for millions of people,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “At the same time, these gains cannot be taken for granted. Protecting and expanding them will require sustained support and investment, so that together we can continue advancing the vision set out in WHO’s Constitution: the highest attainable standard of health as a right for all.”
The WHO Results Report is released annually ahead of the World Health Assembly to assess progress and review achievements and challenges in implementing WHO’s programme budget.
Compared with previous editions, the 2025 report features stronger evidence-based reporting and clearer prioritization across country, regional and global levels, providing a more data-driven picture of where progress has been made and where further effort is needed. The full report will be presented by the Director-General at the Seventy-ninth World Health Assembly (18–23 May 2026).
This latest Results Report shows meaningful – but incomplete – progress across 46 outcome indicators aligned with the 2030 Agenda for Sustainable Development reflecting joint accountability between WHO and its Member States. In addition, 121 output indicators are used to specifically assess the performance of the WHO Secretariat.
Overall, approximately half of the output indicators were not achieved, particularly in emergency-prone and resource-constrained settings. For all three targets, financial pressures and WHO’s realignment process had several immediate consequences, such as reduced human resource capacity for delivery, limited technical support, and slowing programme implementation.
Progress towards universal health coverage was driven by expanded coverage of services for communicable diseases, including HIV and tuberculosis, prevention of bacterial diseases through improved sanitation and an expanding health workforce. However, gaps persist in areas such as diabetes management, measles surveillance and financial protection.
Progress under protection from health emergencies reflects advances in pandemic preparedness, early warning systems, prevention and response capacity. These gains were supported in part by the adopted Pandemic Agreement and the revised International Health Regulations. Areas requiring complex implementation – such as disease detection, emergency response, and polio eradication and transition – remain more challenging, reflecting constraints in country capacity, financing and operations.
Progress towards better health and well-being was driven by improvements in access to clean household energy, water, sanitation and hygiene, and reductions in air pollution, tobacco use and alcohol consumption. WHO’s global guidance, technical tools, standards and networks played a significant role in supporting these achievements.
The Results Report highlights several areas where WHO’s technical leadership and convening role delivered clear impact:
The report notes that a large share of WHO’s funding remains highly earmarked for specific thematic areas, which continues to limit strategic allocation in line with organizational priorities.
As the global financial landscape becomes more constrained, sustained and flexible financing will be essential to safeguard health gains, reduce persistent inequities, and enable WHO to deliver on its mandate – particularly in countries and communities most in need – for a healthier, safer, and fairer world for all.
Editor’s note
Established under GPW 13, WHO’s Triple Billion targets aimed to ensure that, by the end of 2025 compared with 2018 levels, one billion more people benefit from universal health coverage; one billion more people are better protected from health emergencies; and one billion more people enjoy better health and well-being.
Correction
On 1 May 2026, a correction was made to the paragraph below:
This latest Results Report shows meaningful – but incomplete – progress across 46 outcome indicators and 121 output indicators that are specifically focused on the performance of the WHO Secretariat. These indicators are aligned with the 2030 Agenda for Sustainable Development reflecting joint accountability between WHO and its Member States.
This was changed to:
This latest Results Report shows meaningful – but incomplete – progress across 46 outcome indicators aligned with the 2030 Agenda for Sustainable Development reflecting joint accountability between WHO and its Member States. In addition, 121 output indicators are used to specifically assess the performance of the WHO Secretariat.
In a landmark achievement for Caribbean public health, the World Health Organization (WHO) congratulates The Bahamas for becoming the latest Caribbean nation to be certified as having eliminated the mother-to-child transmission of HIV.
“I congratulate The Bahamas on this outstanding achievement, which solidifies years of political commitment, and the dedication of health workers,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “By ensuring that children are born free of HIV, we are securing a healthier, brighter future for the next generation.”
“This achievement reflects sustained political commitment and strong national leadership, alongside the dedication and compassion of the health workforce,” said Dr Jarbas Barbosa, Director of the Pan American Health Organization (PAHO) and WHO Regional Director for the Americas. “As we look ahead, this milestone is not only a moment of national pride but also an opportunity to build on this success, advancing efforts to end HIV and other communicable diseases as public health threats across the Caribbean and the Americas.”
The Bahamas achieved this milestone by pioneering a comprehensive and inclusive health-care model. Key to this success has been the provision of universal antenatal care to all pregnant women, regardless of nationality or legal status, across both public and private facilities. This approach is supported by a strong, integrated laboratory network and a rigorous testing protocol that screens women at their first antenatal appointment and again in the third trimester.
Elimination of mother-to-child transmission (EMTCT) interventions in The Bahamas are fully integrated into antenatal care standards and norms and implemented under the Maternal and Child Health (MCH) programme. MCH coordinates with the National Infectious Disease Programme, which oversees the prevention and treatment of HIV and other sexually transmitted infections (STI). This includes the introduction of pre-exposure prophylaxis (PrEP) for HIV prevention, also offered to pregnant women. To ensure continuity of care, the health system maintains adequate monitoring for HIV-positive mothers and exposed infants, provides multi-month dispensing of antiretroviral medicines, and offers STI treatment and family planning services free of charge.
“For years, The Bahamas have been working very hard to address the situation of HIV/AIDS,” said Dr Michael Darville, Minister of Health and Wellness of The Bahamas. “A lot of people have been involved in us achieving this great milestone – our nurses in our public health system, our nurses and doctors in our tertiary health-care system and, by extension, all of the clinics spread throughout our archipelago.”
From Cuba, the first country in the world to be certified, and Brazil – certified last year, The Bahamas now joins a prestigious group of 12 countries and territories in the Region of the Americas at the forefront of the EMTCT movement. The Bahamas will continue efforts to sustain these standards through integrated primary care and continuous surveillance.
To receive WHO certification, countries must prove they have sustained the following:
“Latin America and the Caribbean has long been a beacon of progress in this global effort. From Cuba – the first country in the world to be certified – to Brazil’s certification last year, and now to The Bahamas, the region continues to lead with ambition and determination. Today, more than half of all countries and territories that have achieved elimination are from this region. This is a legacy of leadership that inspires the world,” said Anurita Bains, Global Associate Director for HIV/AIDS at UNICEF.
“The Bahamas are showing that eliminating mother-to-child transmission HIV and other sexually transmitted infections is possible,” said Winnie Byanyima, UNAIDS Executive Director. “This achievement reflects political will for steady investment in primary health care and the work of health teams and people living with and most affected by HIV. When women can test early in pregnancy, start treatment quickly, and stay in care, every child has a better chance of being born free of HIV and other STIs.”
The Bahamas’ success is part of the broader EMTCT Plus Initiative, which aims to eliminate mother-to-child transmission of HIV, syphilis, hepatitis B, and congenital Chagas disease. Implemented in collaboration with UNICEF and UNAIDS, the initiative is embedded within PAHO’s Elimination Initiative, a regional effort to eliminate more than 30 communicable diseases and related conditions in the Americas by 2030.